Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Northwest Biotherapeutics Inc. buy krebskrebs

Northwest Biotherapeutics Inc.
Start price
€1.10
19.04.21 / 50%
Target price
€1.40
19.04.22
Performance (%)
-15.45%
End price
€0.93
20.04.22
Summary
This prediction ended on 20.04.22 with a price of €0.93. The prediction for Northwest Biotherapeutics Inc. disappointed with a performance of -15.45%. krebskrebs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Northwest Biotherapeutics Inc. -3.433% -3.433% -3.017% -63.710%
iShares Core DAX® 2.594% -1.861% 13.242% 16.867%
iShares Nasdaq 100 3.553% -2.064% 38.293% 45.898%
iShares Nikkei 225® 0.687% -8.704% 17.510% 2.760%
iShares S&P 500 2.209% -1.988% 27.632% 42.955%

Comments by krebskrebs for this prediction

In the thread Northwest Biotherapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -15.45%
Target price 1.400
Change
Ends at

Buy mit Kursziel 1,4

krebskrebs 
0
Report Share
19.04.21
In the thread Trading Northwest Biotherapeutics Inc.
Prediction Buy
Perf. (%) -15.45%
Target price 1.400
Change
Ends at 19.04.22

Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

krebskrebs 
0
Report Share
20.04.22